Mifepristone, Title X and abortion access surface in confirmation hearing; nominee says he will follow president's policies
Loading...
Summary
Abortion policy and regulation of the medication mifepristone were major topics Thursday as senators pressed Robert F. Kennedy Jr. on whether he would use HHS authority to restrict access if confirmed as secretary of Health and Human Services.
Abortion policy and regulation of the medication mifepristone were recurring subjects at the Senate Finance Committee hearing for Robert F. Kennedy Jr., reflecting senators’ concerns about whether the nominee would use HHS authority to restrict access.
Sen. Ron Wyden asked whether Kennedy would “abuse his power as our country's chief health officer to essentially implement a national abortion ban by restricting access to the safe and legal medication” mifepristone. Kennedy said he would study the drug’s safety at the direction of the president and that President Trump had asked him to "look at safety issues" related to mifepristone; he said the president had not given him a final policy direction.
Title X and family‑planning funding also drew specific questions. Sen. James Lankford and others asked whether Kennedy would support President Trump’s prior Title X policy changes restricting promotion or referral for abortion as part of Title X‑funded programs. Kennedy said he is “100% behind” President Trump’s policy on Title X and that he would implement the president’s priorities if confirmed.
Why it matters: HHS and its subagencies (including FDA and HRSA) play a central role in regulation and funding of family‑planning services. Actions by the secretary, or by agency regulatory changes, can affect access to medication abortion and Title X funding conditions.
Quotes
- Sen. Ron Wyden: “Women deserve to know if Mr. Kennedy will abuse his power … to essentially implement a national abortion ban by restricting access to the safe and legal medication.”
- Robert F. Kennedy Jr.: “President Trump has asked me to study the safety of mifepristone. He has not yet taken a stand on, on how to regulate it. Whatever he does, I will implement those policies.”
- Sen. James Lankford: Asked directly whether the nominee would support reinstating the administration’s prior Title X rule; Kennedy replied he would support President Trump’s policies on Title X.
What senators sought and what the nominee pledged
Several senators pressed Kennedy for unequivocal positions on reproductive‑health protections and emergency care. Sen. Catherine Cortez Masto asked whether federal law (EMTALA) and HHS enforcement would protect emergency care for pregnant people in states that restrict abortion; Kennedy deferred to legal constraints and said he would follow the law and the president’s policy directions. Kennedy repeatedly said he serves at the pleasure of the president and would implement presidential policy on Title X and other executive decisions.
Ending
The exchange left senators divided on whether the nominee’s assurances — that he would “study” safety issues while pledging to carry out the president’s directives — are sufficient on a subject many said carries immediate, personal consequences for patients and providers.
